Search for Clinical Trial Results

Sponsored By

Membranous Nephropathy - 27 Studies Found

Status Study
Active, not recruiting Study Name: MEmbranous Nephropathy Trial Of Rituximab
Condition: Idiopathic Membranous Nephropathy
Date: 2010-08-10
Interventions:
  • Drug: Rituximab 1000 mg, I.V.

Withdrawn Study Name: Aliskiren in Patients With Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Date: 2010-03-24
Interventions: Drug: Aliskiren Aliskiren dose will begin with 150mg per day and later up-titrated to the maximum availa
Not yet recruiting Study Name: Adrenocorticotropic Hormone in Membranous Nephropathy
Condition: Membranous Nephropathy
Date: 2017-01-17
Interventions: Drug: ACTHar for 6 months Other Names:
Recruiting Study Name: Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy
Condition: MEMBRANOUS NEPHROPATHY
Date: 2013-09-19
Interventions:
  • Drug: TACROLIMUS Initial dose:
Active, not recruiting Study Name: Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Date: 2011-12-09
Interventions:
  • Drug: symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, An
Completed Study Name: Rituximab in Membranous Nephropathy
Condition: Membranous Nephropathy
Date: 2007-01-19
Interventions: Drug: Rituximab
Active, not recruiting Study Name: Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Date: 2013-04-29
Interventions:
  • Drug: Losartan Tablets & QingReMoShen Granule
Completed Study Name: Rituximab in the Treatment of Idiopathic Membranous Nephropathy
Condition: Membranous Nephropathy
Date: 2006-11-29
Interventions: Drug: Rituximab Patients will received rituximab 4 weekly doses of rituximab 375 mg/m2 at baseline. Pati
Recruiting Study Name: Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy
Condition: Membranous Nephropathy
Date: 2014-07-22
Interventions: Procedure: Blood and urine analysis creatinine, albumin, blood electrolytes, proteinuria / creatinine in
Completed Study Name: Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Date: 2008-06-09
Interventions: Drug: tetracosactide hexacetaat Intramuscular injections with tetracosactide hexacetaat (Synacthen Depot
Next >>>